IRCZX
Price
$15.57
Change
-$0.00 (-0.00%)
Updated
Jun 2 closing price
Net Assets
1.3B
PICRX
Price
$44.56
Change
-$0.24 (-0.54%)
Updated
Jun 2 closing price
Net Assets
342.72M
Interact to see
Advertisement

IRCZX vs PICRX

Header iconIRCZX vs PICRX Comparison
Open Charts IRCZX vs PICRXBanner chart's image
IRCZX vs PICRX Comparison Chart in %
View a ticker or compare two or three
VS
IRCZX vs. PICRX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRCZX is a Hold and PICRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
IRCZX has more cash in the bank: 1.3B vs. PICRX (343M). PICRX pays higher dividends than IRCZX: PICRX (5.61) vs IRCZX (2.10). IRCZX was incepted earlier than PICRX: IRCZX (10 years) vs PICRX (23 years). PICRX (1.78) is less costly to investors than IRCZX (1.10). IRCZX is a more actively managed with annual turnover of: 57.00 vs. PICRX (30.00). IRCZX (0) and PICRX (0) have matching initial minimum investment requirements. IRCZX annual gain was more profitable for investors over the last year : 13.92 vs. PICRX (3.54). IRCZX return over 5 years is better than : 27.65 vs. PICRX (7.68).
IRCZXPICRXIRCZX / PICRX
Total Expense Ratio1.101.7364%
Annual Report Gross Expense Ratio1.101.7862%
Fund Existence10 years23 years-
Gain YTD14.2332.941484%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.3B343M380%
Annual Yield % from dividends2.105.6137%
Returns for 1 year13.923.54394%
Returns for 3 years54.7337.26147%
Returns for 5 years27.657.68360%
Returns for 10 years79.2250.36157%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OFIX9.720.45
+4.85%
Orthofix Medical
USEG1.080.01
+0.93%
US Energy Corp
BSAAU11.13N/A
N/A
Best Spac I Acquisition Corp
AAL13.93-0.41
-2.86%
American Airlines Group
VRDN15.86-1.10
-6.49%
Viridian Therapeutics